Search research articles
Contact Us
Filters
Showing results (161-170 of 170) with videos related to
Page
of 17
Sort By:
You have reached the last page of results.
This site can display upto 170 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2026
Safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy from a first-in-human study of volrustomig, a novel PD-1/CTLA-4 bispecific antibody
Ben Tran, Mark Voskoboynik, Sang-We Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 1, 2024
A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer
Tanya Dorff, Lisa G Horvath, Karen Autio, et al.
NPJ Precision Oncology
|
May 7, 2026
A roadmap for establishing institutional readiness for cellular therapies targeting solid tumours and autoimmune diseases
Sarah Childs, David Ma, Elizabeth Houghton, et al.
The Oncologist
|
October 6, 2025
Guiding first-line treatment decisions in advanced urothelial carcinoma: a global survey
Enrique Grande, Joaquim Bellmunt, Syed A Hussain, et al.
Ebiomedicine
|
October 17, 2021
Overcoming enzalutamide resistance in metastatic prostate cancer by targeting sphingosine kinase
Hui-Ming Lin, Blossom Mak, Nicole Yeung, et al.
Gut
|
February 9, 2018
Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study
Jeanne Tie, Joshua D Cohen, Yuxuan Wang, et al.
The Lancet. Oncology
|
July 5, 2025
First-in-human results of terbium-161 [<sup>161</sup>Tb]Tb-PSMA-I&T dual beta-Auger radioligand therapy in patients with metastatic castration-resistant prostate cancer (VIOLET): a single-centre, single-arm, phase 1/2 study
James P Buteau, Louise Kostos, Price A Jackson, et al.
Cancer Discovery
|
January 9, 2021
Design and Efficacy of a Monovalent Bispecific PD-1/CTLA4 Antibody That Enhances CTLA4 Blockade on PD-1<sup>+</sup> Activated T Cells
Simon J Dovedi, Matthew J Elder, Chunning Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2021
Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium
Jörg Beyer, Laurence Collette, Nicolas Sauvé, et al.
Journal for Immunotherapy of Cancer
|
February 15, 2019
Correction to: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018)
Sneha Berry, Nicolas Giraldo, Peter Nguyen, et al.
Page
of 17
Search research articles
Search
Showing results (161-170 of 170) with videos related to
Sort By:
Page
of 17
You have reached the last page of results.
This site can display upto 170 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2026
Safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy from a first-in-human study of volrustomig, a novel PD-1/CTLA-4 bispecific antibody
Ben Tran, Mark Voskoboynik, Sang-We Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 1, 2024
A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer
Tanya Dorff, Lisa G Horvath, Karen Autio, et al.
NPJ Precision Oncology
|
May 7, 2026
A roadmap for establishing institutional readiness for cellular therapies targeting solid tumours and autoimmune diseases
Sarah Childs, David Ma, Elizabeth Houghton, et al.
The Oncologist
|
October 6, 2025
Guiding first-line treatment decisions in advanced urothelial carcinoma: a global survey
Enrique Grande, Joaquim Bellmunt, Syed A Hussain, et al.
Ebiomedicine
|
October 17, 2021
Overcoming enzalutamide resistance in metastatic prostate cancer by targeting sphingosine kinase
Hui-Ming Lin, Blossom Mak, Nicole Yeung, et al.
Gut
|
February 9, 2018
Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study
Jeanne Tie, Joshua D Cohen, Yuxuan Wang, et al.
The Lancet. Oncology
|
July 5, 2025
First-in-human results of terbium-161 [<sup>161</sup>Tb]Tb-PSMA-I&T dual beta-Auger radioligand therapy in patients with metastatic castration-resistant prostate cancer (VIOLET): a single-centre, single-arm, phase 1/2 study
James P Buteau, Louise Kostos, Price A Jackson, et al.
Cancer Discovery
|
January 9, 2021
Design and Efficacy of a Monovalent Bispecific PD-1/CTLA4 Antibody That Enhances CTLA4 Blockade on PD-1<sup>+</sup> Activated T Cells
Simon J Dovedi, Matthew J Elder, Chunning Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2021
Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium
Jörg Beyer, Laurence Collette, Nicolas Sauvé, et al.
Journal for Immunotherapy of Cancer
|
February 15, 2019
Correction to: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018)
Sneha Berry, Nicolas Giraldo, Peter Nguyen, et al.
Page
of 17